Try our Advanced Search for more refined results

March 24, 2020

Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al

Track this case

Case Number:

1:20-cv-00415

Court:

Delaware

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Judge:

Richard G. Andrews

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 25, 2020

    Novartis Wants Lupin's Generic Heart Failure Drug Blocked

    Novartis has again accused Lupin of infringing patents covering the chronic heart failure drug Entresto by requesting U.S. Food and Drug Administration approval for a generic version of the blockbuster medication.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login